Jonathan Pai

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Joseph M. Herman, Daniel T. Chang, Karyn A. Goodman et al. · Cancer · 2014 · 526 citations · Full text

Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy

Avani Satish Dholakia, Muhammad Chaudhry, Jeffrey P. Leal et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 77 citations · Full text

Survival Outcomes, Oncology, Pancreatic Cancer +8

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Aaron T. Wild, Susan M. Hiniker, Daniel T. Chang et al. · PubMed · 2013 · 73 citations · Full text

Adaptive Radiotherapy, Radiation Medicine, Surgical Oncology +14

The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer

Margaret M. Kozak, Rie von Eyben, Jonathan Pai et al. · American Journal of Clinical Oncology · 2015 · 52 citations

Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer

Margaret M. Kozak, Eric M. Anderson, Rie von Eyben et al. · Pancreas · 2015 · 50 citations